Synergistic Efficacy of Integrated Care (Syzygium Jambolanum + Conventional Therapy) Vs Conventional Therapy Alone In Managing Type 2 Diabetes Mellitus: Randomised Controlled Trial – A Case Study

Authors

  • Preeti Jha
  • Dushant Trigotra
  • Rinku Bishwas

Keywords:

N\A

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from insulin resistance and/or impaired insulin secretion. Despite the availability of conventional therapies, achieving optimal glycemic control remains challenging in many patients. Syzygium jambolanum, a well-known homoeopathic medicine, has traditionally been used in the management of diabetes. This study explored the synergistic efficacy of integrated care (Syzygium jambolanum along with conventional therapy) compared with conventional therapy alone in patients with Type 2 Diabetes Mellitus over a 6-month follow-up period.

Aim: To study the efficacy of integrated care (Syzygium jambolanum + conventional therapy) versus conventional therapy alone in the management of Type 2 Diabetes Mellitus.

Objectives:

  • To assess the efficacy of integrated care in cases of Type 2 Diabetes Mellitus using glycemic parameters before and after treatment.

 

  • To compare the changes in HbA1c, fasting blood glucose (FBG), and postprandial blood glucose (PPBG) between the integrated care group and the conventional therapy group.

 

• To evaluate the safety and tolerability of integrated care in patients with Type 2 Diabetes Mellitus

Downloads

Download data is not yet available.

References

World Health Organization. Prevention of diabetes mellitus. Geneva: WHO; 2005.

2. Inzucchi SE, et al. Management of hyperglycemia in type 2 diabetes. Diabetologia. 2012;55:1577–96.

3. Hahnemann S. Organon of Medicine. 6th ed. New Delhi: B Jain Publishers; 2002.

4. Boericke W. Pocket Manual of Homoeopathic Materia Medica. New Delhi: B Jain; 2013.

5. Grover JK, Yadav S, Vats V. Medicinal plants and diabetes. J Ethnopharmacol. 2002;81:81–100.

6. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: IDF; 2021.

7. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus. Diabetes. 1979;28:1039–57.

8. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2003;26(Suppl 1):S33–50.

9. Ayyanar M, Subash-Babu P. Syzygium cumini review. Asian Pac J Trop Biomed. 2012;2:240–6.

10. World Health Organization. Traditional medicine strategy. Geneva: WHO; 2013.

11. Innes KE, Vincent HK. Yoga for type 2 diabetes. J Diabetes Res. 2016;2016:6979370

Downloads

Published

2025-06-12

How to Cite

1.
Jha P, Trigotra D, Bishwas R. Synergistic Efficacy of Integrated Care (Syzygium Jambolanum + Conventional Therapy) Vs Conventional Therapy Alone In Managing Type 2 Diabetes Mellitus: Randomised Controlled Trial – A Case Study. J Neonatal Surg [Internet]. 2025 Jun. 12 [cited 2026 Sep. 5];14(32S):11105-1. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10482

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.